drugset / Trial / NCT02967302

NEUROIMPA - Intraarticular Application of Opioids in Chronic Arthritis of the Knee Joint

NCT02967302

Phase 2/3 Unknown 112 enrolled Hildrun Haibel DLR German Aerospace Center · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

To investigate pain and inflammatory parameters (cytokines, immune cells) in knee joint tissue of chronic arthritis patients following intraarticular (i.a.) injections of morphine, a standard steroid or placebo. The primary hypothesis is that i.a. morphine results in significantly lower pain scores and supplemental analgesic consumption than placebo during the first week after injection, an efficacy comparable to standard i.a. steroid (triamcinolone) medication.

Timeline

Start
2015-08
Primary completion
2021-12
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified 3 mg Other
Comparator Triamcinolone Other / unclassified 40 mg Other

Indications